PBP 2a mutations producing very-high-level resistance to beta-lactamsKATAYAMA, Yuki; ZHANG, Hong-Zhong; CHAMBERS, Henry F et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 453-459, issn 0066-4804, 7 p.Article

IDEXX SNAP^® Beta-Lactam ST Validation for Penicillin G DetectionWALDRON, Travis T; BOISON, Joe; AGIN, James et al.Journal of AOAC International. 2013, Vol 96, Num 6, pp 1343-1349, issn 1060-3271, 7 p.Article

The future of the β-lactamsLLARRULL, Leticia I; TESTERO, Sebastian A; FISHER, Jed F et al.Current opinion in microbiology. 2010, Vol 13, Num 5, pp 551-557, issn 1369-5274, 7 p.Article

Carbapenems: Past, Present, and FuturePAPP-WALLACE, Krisztina M; ENDIMIANI, Andrea; TARACILA, Magdalena A et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 11, pp 4943-4960, issn 0066-4804, 18 p.Article

Simple approach to β-lactam derivatives from N-acylimidazolesNAHMANY, Moshe; MELMAN, Artem.Journal of organic chemistry. 2006, Vol 71, Num 15, pp 5804-5806, issn 0022-3263, 3 p.Article

Antimicrobials : β-Lactam antibiotic resistance : a current structural perspectiveWILKE, Mark S; LOVERING, Andrew L; STRYNADKA, Natalie C. J et al.Current opinion in microbiology. 2005, Vol 8, Num 5, pp 525-533, issn 1369-5274, 9 p.Article

Allergie aux β-lactamines : ALLERGO-IMMUNOLOGIE = β-lactam antibiotics allergiesCOMTE, D; PETITPIERRE, S; SPERTINI, F et al.Revue médicale suisse. 2012, Vol 8, Num 337, issn 1660-9379, 836-842 [6 p.]Article

Exposure to diverse antimicrobials induces the expression of qnrB1, qnrD and smaqnr genes by SOS-dependent regulationBRIALES, A; RODRIGUEZ-MARTINEZ, J. M; VELASCO, C et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 12, pp 2854-2859, issn 0305-7453, 6 p.Article

Prolonged β-Lactam Infusion for Gram-negative InfectionsTAMMA, Pranita D; JENH, Alice M; MILSTONE, Aaron M et al.The Pediatric infectious disease journal. 2011, Vol 30, Num 4, pp 336-337, issn 0891-3668, 2 p.Article

Control of fluxes towards antibiotics and the role of primary metabolism in production of antibioticsGUNNARSSON, Nina; ELIASSON, Anna; NIELSEN, Jens et al.Advances in biochemical engineering, biotechnology. 2004, Vol 88, pp 137-178, issn 0724-6145, 42 p.Article

A Bacteroides thetaiotamicron porin that could take part in resistance to β-lactamsBEHRA-MIELLET, J; CALVET, L; DUBREUIL, L et al.International journal of antimicrobial agents. 2004, Vol 24, Num 2, pp 135-143, issn 0924-8579, 9 p.Article

Penicillin: the medicine with the greatest impact on therapeutic outcomesKARDOS, Nelson; DEMAIN, Arnold L.Applied microbiology and biotechnology. 2011, Vol 92, Num 4, pp 677-687, issn 0175-7598, 11 p.Article

New developments in carbapenemsKATTAN, J. N; VILLEGAS, M. V; QUINN, J. P et al.Clinical microbiology and infection. 2008, Vol 14, Num 12, pp 1102-1111, issn 1198-743X, 10 p.Article

Assessing substrate acceptance and enantioselectivity of yeast reductases in reactions with substituted α-keto β-lactamsYAN YANG; KAYSER, Margaret M; ROCHON, Fernande D et al.Journal of molecular catalysis. B, Enzymatic. 2005, Vol 32, Num 5-6, pp 167-174, issn 1381-1177, 8 p.Article

An Ongoing National Intervention to Contain the Spread of Carbapenem-Resistant EnterobacteriaceaeSCHWABER, Mitchell J; CARMELI, Yehuda.Clinical infectious diseases. 2014, Vol 58, Num 5, pp 697-703, issn 1058-4838, 7 p.Article

PBP5, PBP6 and DacD play different roles in intrinsic β-lactam resistance of Escherichia coliKUMAR SARKAR, Sujoy; DUTTA, Mouparna; CHOWDHURY, Chiranjit et al.Microbiology (Reading). 2011, Vol 157, pp 2702-2707, issn 1350-0872, 6 p., 9Article

Importance of Infusion Volume and Pump Characteristics in Extended Administration of β-Lactam AntibioticsCLAUS, Barbara; BUYLE, Franky; ROBAYS, Hugo et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 11, issn 0066-4804, p. 4950Article

Ceftobiprole: a new β-lactam antibioticSTEIN, R. A; GOETZ, R. M; GANEA, G. M et al.International journal of clinical practice (Esher). 2009, Vol 63, Num 6, pp 930-943, issn 1368-5031, 14 p.Article

DoripenemPATERSON, David L; DEPESTEL, Daryl D.Clinical infectious diseases. 2009, Vol 49, Num 2, pp 291-298, issn 1058-4838, 8 p.Article

Efficacy and safety of cefepimeTOWNE, Trent G; LEWIS, James S; ECHEVARRIA, Kelly et al.Lancet. Infectious diseases (print). 2009, Vol 9, Num 1, pp 4-7, issn 1473-3099, 4 p.Article

Identification and Characterization of NocR as a Positive Transcriptional Regulator of the β-Lactam Nocardicin A in Nocardia uniformisDAVIDSEN, Jeanne M; TOWNSEND, Craig A.Journal of bacteriology. 2009, Vol 191, Num 3, pp 1066-1077, issn 0021-9193, 12 p.Article

Model system to evaluate the effect of ampD mutations on AmpC-mediated β-lactam resistanceSCHMIDTKE, Amber J; HANSON, Nancy D.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 6, pp 2030-2037, issn 0066-4804, 8 p.Article

Antimicrobials : The threat of antibiotic resistance in Gram-negative pathogenic bacteria : β-lactams in peril!THOMSON, Jodi M; BONOMO, Robert A.Current opinion in microbiology. 2005, Vol 8, Num 5, pp 518-524, issn 1369-5274, 7 p.Article

High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitutionCARTELLE, Monica; DEL MAR TOMAS, Maria; MOLINA, Francisca et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 6, pp 2308-2313, issn 0066-4804, 6 p.Article

Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinamLOKRANTZ, C.-M; ERIKSSON, B; ROSEN, I et al.Acta neurologica scandinavica. 2004, Vol 109, Num 4, pp 297-301, issn 0001-6314, 5 p.Article